Brian L. Kotzin's Net Worth
$1.35 Million
Who is Brian L. Kotzin?
Brian L. Kotzin has an estimated net worth of $1.35 Million. This is based on reported shares across multiple companies, which include RIGEL PHARMACEUTICALS INC, BIORA THERAPEUTICS, INC., and Kyverna Therapeutics, Inc..
SEC CIK
Brian L. Kotzin's CIK is 0001715332
Past Insider Trading and Trends
2021 was Brian L. Kotzin's most active year for acquiring shares with 4 total transactions. Brian L. Kotzin's most active month to acquire stocks was the month of April. 2023 was Brian L. Kotzin's most active year for disposing of shares, totalling 1 transactions. Brian L. Kotzin's most active month to dispose stocks was the month of December. 2022 saw Brian L. Kotzin paying a total of $0.00 for 299,964 shares, this is the most they've acquired in one year. In 2023 Brian L. Kotzin cashed out on 44 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RIGEL PHARMACEUTICALS INC (RIGL) Snapshot price: $13.32
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +33.33% | 25K |
—
|
—
| 100K |
May 25
| |||
Form 4
| +50.00% | 25K |
—
|
—
| 75K |
May 26
| |||
Form 4
| +100.00% | 25K |
—
|
—
| 50K |
May 20
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIORA THERAPEUTICS, INC. (BIOR) Snapshot price: $0.655
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +68.51% | 12.5K |
—
|
—
| 30.75K |
Jun 5
| |||
Form 4
| +217.54% | 12.5K |
—
|
—
| 18.25K |
Jun 14
| |||
Form 4
| -100.00% | -44.00 |
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +202.35% | 96.15K |
—
|
—
| 143.67K |
Jun 15
| |||
Form 4
| +159.17% | 29.18K |
—
|
—
| 47.52K |
Jun 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kyverna Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||